Moreover, progressive outgrowth of control BRAFV600E tumours and efficient immune control of Ptgs1/Ptgs2−/− BRAFV600E tumours was unchanged following tumour transplantation to the same lymph drainage site (Extended Data Fig. 3h). This evidence concerns the gene PTGS1 and neoplasm.